Accession Number: | 0001209191-21-040092 |
Date: | 2021-06-09 |
Issuer: | PACIRA BIOSCIENCES, INC. (PCRX) |
Original Submission Date: |
RIKER LAUREN BULLARO
C/O PACIRA BIOSCIENCES, INC.
5 SYLVAN WAY, SUITE 300
PARSIPPANY, NJ 07054
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-06-09 | A | 2,600 | a | $0.00 | 14,734 | direct | ||
COMMON STOCK | 2021-06-11 | S | 2,003 | d | $59.85 | 12,731 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 60.96 | 2021-06-09 | deemed execution date | A | 6,500 (a) | 2031-06-09 | common stock 6,500 | $60.96 | 6,500 | direct |
ID | footnote |
---|---|
f1 | represents restricted stock units that vest in four equal annual installments beginning on june 3, 2022, provided that the reporting person remains in continuous service with the issuer as of each vesting date. each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. |
f2 | the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $59.820 to $59.845, inclusive. the reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth this footnote. |
f3 | the stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. |